144 related articles for article (PubMed ID: 38368603)
41. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
Grumbach MM; Bin-Abbas BS; Kaplan SL
Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
[TBL] [Abstract][Full Text] [Related]
42. Spotlight on Lonapegsomatropin Once-Weekly Injection and Its Potential in the Treatment of Growth Hormone Deficiency in Pediatric Patients.
Miller BS; Yuen KCJ
Drug Des Devel Ther; 2022; 16():2055-2066. PubMed ID: 35791404
[TBL] [Abstract][Full Text] [Related]
43. Nonclinical pharmacokinetic and pharmacodynamic characterisation of somapacitan: A reversible non-covalent albumin-binding growth hormone.
Thygesen P; Andersen HS; Behrens C; Fels JJ; Nørskov-Lauritsen L; Rischel C; Johansen NL
Growth Horm IGF Res; 2017 Aug; 35():8-16. PubMed ID: 28595133
[TBL] [Abstract][Full Text] [Related]
44. Use of PEGylated Recombinant Human Growth Hormone in Chinese Children with Growth Hormone Deficiency: A 24-Month Follow-Up Study.
Qiao Y; Wang Z; Han J; Li G
Int J Endocrinol; 2019; 2019():1438723. PubMed ID: 31641350
[TBL] [Abstract][Full Text] [Related]
45. Health-related quality of life in pre-pubertal children with pediatric growth hormone deficiency: 12-month results from a phase 3 clinical trial of once-weekly somatrogon versus once-daily somatropin.
Loftus J; Quitmann J; Valluri SR
Curr Med Res Opin; 2024 Feb; 40(2):175-184. PubMed ID: 38053515
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of the growth response of children with growth hormone deficiency according to the peak growth hormone levels in provocation tests.
Donbaloğlu Z; Singin B; Acar S; Bedel A; Barsal Çetiner E; Aydın Behram B; Parlak M; Tuhan H
Arch Pediatr; 2023 Nov; 30(8):573-579. PubMed ID: 37802668
[TBL] [Abstract][Full Text] [Related]
47. Long-term Pegylated GH for Children With GH Deficiency: A Large, Prospective, Real-world Study.
Hou L; Huang K; Gong C; Luo F; Wei H; Liang L; Du H; Zhang J; Zhong Y; Chen R; Chen X; Pan J; Jin X; Zeng T; Liao W; Liu D; Lan D; Zhu S; Dong Z; Ma H; Yang Y; Xiong F; Lu P; Cheng S; Gu X; Jin R; Liu Y; Wu J; Xu X; Chen L; Dong Q; Pan H; Su Z; Liu L; Luo X; Ni S; Chen Z; Hu Y; Wang C; Liu J; Liu L; Lu B; Wang X; Wang Y; Yang F; Zhang M; Cao L; Liu G; Yao H; Zhan Y; Dai M; Li G; Li L; Liu Y; Wang K; Xiao Y; Zhang X; Dong J; Gu Z; Ying L; Huang F; Liu Y; Liu Z; Ye J; Zhao D; Hu X; Jiang Z; Ye K; Zhu H; Chen S; Chen X; Wan N; Xu Z; Yin Q; Zhang H; Huang X; Yin J; Zhang H; Li P; Yin P; Fu J; Luo X
J Clin Endocrinol Metab; 2023 Jul; 108(8):2078-2086. PubMed ID: 36669772
[TBL] [Abstract][Full Text] [Related]
48. Adult height after growth hormone treatment in Japanese children with idiopathic growth hormone deficiency: analysis from the KIGS Japan database.
Fujieda K; Tanaka T; Takano K; Chihara K; Seino Y; Irie M;
J Pediatr Endocrinol Metab; 2011; 24(7-8):457-62. PubMed ID: 21932582
[TBL] [Abstract][Full Text] [Related]
49. Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study.
Deal CL; Steelman J; Vlachopapadopoulou E; Stawerska R; Silverman LA; Phillip M; Kim HS; Ko C; Malievskiy O; Cara JF; Roland CL; Taylor CT; Valluri SR; Wajnrajch MP; Pastrak A; Miller BS
J Clin Endocrinol Metab; 2022 Jun; 107(7):e2717-e2728. PubMed ID: 35405011
[TBL] [Abstract][Full Text] [Related]
50. A Randomized Phase 2 Study of Long-Acting TransCon GH vs Daily GH in Childhood GH Deficiency.
Chatelain P; Malievskiy O; Radziuk K; Senatorova G; Abdou MO; Vlachopapadopoulou E; Skorodok Y; Peterkova V; Leff JA; Beckert M;
J Clin Endocrinol Metab; 2017 May; 102(5):1673-1682. PubMed ID: 28201598
[TBL] [Abstract][Full Text] [Related]
51. Correction to: "Effective GH Replacement With Somapacitan in Children With GHD: REAL4 2-year Results and After Switch From Daily GH".
J Clin Endocrinol Metab; 2023 Nov; 108(12):e1762. PubMed ID: 37619571
[No Abstract] [Full Text] [Related]
52. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
[TBL] [Abstract][Full Text] [Related]
53. Criteria for First-Year Growth Response to Growth Hormone Treatment in Prepubertal Children With Growth Hormone Deficiency: Do They Predict Poor Adult Height Outcome?
Straetemans S; De Schepper J; Thomas M; Tenoutasse S; Beauloye V; Rooman R
Front Endocrinol (Lausanne); 2019; 10():792. PubMed ID: 31849835
[No Abstract] [Full Text] [Related]
54. The pharmacokinetic and pharmacodynamic properties and short-term outcome of a novel once-weekly PEGylated recombinant human growth hormone for children with growth hormone deficiency.
Liang Y; Zhang C; Wei H; Du H; Zhang G; Yang Y; Zhang H; Gong H; Li P; Song F; Xu Z; He R; Zhou W; Zheng H; Sun L; Luo X
Front Endocrinol (Lausanne); 2022; 13():922304. PubMed ID: 36034448
[TBL] [Abstract][Full Text] [Related]
55. What do we do now that the long-acting growth hormone is here?
Miller BS
Front Endocrinol (Lausanne); 2022; 13():980979. PubMed ID: 36072938
[TBL] [Abstract][Full Text] [Related]
56. Effect of growth hormone therapy on Taiwanese children with growth hormone deficiency.
Huang YH; Wai YY; Van YH; Lo FS
J Formos Med Assoc; 2012 Jul; 111(7):355-63. PubMed ID: 22817812
[TBL] [Abstract][Full Text] [Related]
57. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.
Guevara-Aguirre J; Rosenbloom AL; Vasconez O; Martinez V; Gargosky SE; Allen L; Rosenfeld RG
J Clin Endocrinol Metab; 1997 Feb; 82(2):629-33. PubMed ID: 9024266
[TBL] [Abstract][Full Text] [Related]
58. Basal characteristics and first year responses to human growth hormone (GH) vary according to diagnostic criteria in children with non-acquired GH deficiency (naGHD): observations from a single center over a period of five decades.
Ranke MB; Schweizer R; Binder G
J Pediatr Endocrinol Metab; 2018 Nov; 31(11):1257-1266. PubMed ID: 30332395
[TBL] [Abstract][Full Text] [Related]
59. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
[TBL] [Abstract][Full Text] [Related]
60. The Growth Hormone Deficiency (GHD) Reversal Trial: effect on final height of discontinuation versus continuation of growth hormone treatment in pubertal children with isolated GHD-a non-inferiority Randomised Controlled Trial (RCT).
Brettell E; Högler W; Woolley R; Cummins C; Mathers J; Oppong R; Roy L; Khan A; Hunt C; Dattani M;
Trials; 2023 Aug; 24(1):548. PubMed ID: 37605233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
